Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02843373 · ClinicalTrials.gov registry record
Brain-Based Biomarkers in Response to TMS in MDD
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 54
- Enrollment target
NCT02843373: Completed study, sponsored by Stanford University.
NCT02843373 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02843373 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The overarching goal of this research program is to elucidate causal and directional neural network- level abnormalities in depression, and how they are modulated by an individually-tailored, circuit-directed intervention. By using concurrent TMS and EEG, the investigators can overcome a major limitation of EEG - the inability to demonstrate causality. Here, we plan to recruit patients with medication-resistant depression undergoing rTMS treatment. At multiple time points, we will perform TMS-EEG to investigate the excitability and connectivity profiles of brain networks and how they are modulated during treatment. This study aims to provide objective brain network measures that can predict and track clinical response to TMS treatment. Findings from this study will be utilized to develop a novel, personalized treatment protocol based on individual brain networks.
Primary Outcome
From pre- to post-treatment, improvement will be based on enhanced excitability and connectivity
Interventions
- DEVICE TMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2016-03 |
| Est. Completion | 2019-12 |
What the finished NCT02843373 record still lists
NCT02843373 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which TMS is the first listed.
NCT02843373 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02843373 about?
NCT02843373 is a clinical study titled "Brain-Based Biomarkers in Response to TMS in MDD". The overarching goal of this research program is to elucidate causal and directional neural network- level abnormalities in depression, and how they are modulated by an individually-tailored, circuit-directed intervention. By using concurrent TMS and EEG, the investigators can overcome a major limit...
What is the current status of trial NCT02843373?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2016-03. Estimated completion is 2019-12.
What interventions are being tested in trial NCT02843373?
The interventions under investigation include: TMS (DEVICE).
Who is sponsoring clinical trial NCT02843373?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia